Sign In
Free Newsletter
Hudson Regional Health hosts Aug. 20 job fair
Hudson Regional Health will host an Aug. 20 job fair, seeking to hire nurses, allied health workers and leaders across its Hudson County hospitals.
Hackensack Meridian Health earns Joint Commission AI certification
Hackensack Meridian Health is the first U.S. health system certified by The Joint Commission for responsible AI use in healthcare.
Novo Nordisk, AWS partner on AI drug discovery
Novo Nordisk names AWS its strategic AI partner to accelerate drug discovery and expand artificial intelligence across its business.
J&J gives $300K to modernize Rutgers-Camden nursing simulation lab
J&J gave Rutgers-Camden $300,000 to modernize its nursing simulation lab and fund five scholarships for first-generation nursing students.
Amneal closes $1.1B Kashiv Biosciences acquisition
The combination of Bridgewater-based Amneal Pharmaceuticals and Kashiv Biosciences from Piscataway creates a global leader in biosimilars ahead of a looming Loss of Exclusivity set to hit the market.
NJ-based BMS to build $2.3B Texas manufacturing campus
Lawrenceville-based BMS will invest $2.3 billion to build a 600,000-square-foot Houston manufacturing campus expected to create 500 skilled jobs.
RWJBarnabas Health invests nearly $50M in NJ FQHCs
Since 2024, RWJBarnabas Health has invested $49.35 million in federally qualified health centers in New Jersey to expand access to care statewide.
Vanova Health leases 19,000 square feet at The Eisenhower
Vanova Health leased 19,000 square feet at The Eisenhower in Livingston, adding to recent office leasing activity in Essex County and at the Class A property.
Cooper Health receives $900K grant for new ALS clinic
Cooper Health received nearly $900,000 to establish a multidisciplinary ALS clinic in Camden, expanding specialized care in South Jersey.
Deborah completes $108M hospital expansion in Browns Mills
Deborah Heart and Lung Center completed its $108M Browns Mills expansion, adding private patient suites and new treatment space.
FDA approves Reckitt’s new Mucinex cold, flu medicine
The FDA approves Reckitt's Mucinex 12HR Cold & Fever Multi-Symptom, a new OTC medicine offering up to 12 hours of symptom relief.
AstraZeneca, BMS not pursuing merger talks: Reuters
Reuters says AstraZeneca and Bristol Myers Squibb are not pursuing merger talks, despite earlier reports of a potential $400 billion deal.
